Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the ... MarketWatch (press release) The trial was conducted pursuant to Nile's previously announced collaboration with Medtronic and was an important step towards developing cenderitide as a 90-day outpatient treatment for heart failure patients following admission for acutely ... |
